NEO

NeoGenomics, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$16.54

Price (1 Year)

$19.91 $7.19

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %23.3 / %30
Non-compliant assets / Total market cap %8.4 / %30
Non-compliant revenue / Total income %2.4 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories.

Website

Analysis (Turkish): NEO Hissesi Caiz mi, Helal mi? NeoGenomics, Inc. Katılım Analizi